Aimia (AIM) Competitors C$2.55 -0.04 (-1.54%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines AIM vs. CRON, SLS, TEV, ABT, NOT, PYR, NVO, DNA, VBV, and CUSShould you be buying Aimia stock or one of its competitors? The main competitors of Aimia include Cronos Group (CRON), Solaris Resources (SLS), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), VBI Vaccines (VBV), and Chemtrade Electrochem Inc, (CUS). These companies are all part of the "pharmaceutical products" industry. Aimia vs. Cronos Group Solaris Resources Tervita Absolute Software Co. (ABT.TO) Noront Resources PyroGenesis Canada Inc. (PYR.V) Novo Resources Corp. (NVO.V) Dalradian Resources VBI Vaccines Chemtrade Electrochem Inc, Cronos Group (TSE:CRON) and Aimia (TSE:AIM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership. Is CRON or AIM more profitable? Aimia has a net margin of -26.20% compared to Cronos Group's net margin of -56.43%. Cronos Group's return on equity of -5.29% beat Aimia's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-56.43% -5.29% -3.73% Aimia -26.20%-16.59%-4.93% Does the MarketBeat Community prefer CRON or AIM? Aimia received 320 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 54.18% of users gave Aimia an outperform vote while only 50.74% of users gave Cronos Group an outperform vote. CompanyUnderperformOutperformCronos GroupOutperform Votes6950.74% Underperform Votes6749.26% AimiaOutperform Votes38954.18% Underperform Votes32945.82% Do analysts rate CRON or AIM? Cronos Group currently has a consensus price target of C$3.18, indicating a potential upside of 13.98%. Aimia has a consensus price target of C$4.00, indicating a potential upside of 56.86%. Given Aimia's stronger consensus rating and higher possible upside, analysts clearly believe Aimia is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Aimia 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, CRON or AIM? Cronos Group has higher earnings, but lower revenue than Aimia. Cronos Group is trading at a lower price-to-earnings ratio than Aimia, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos GroupC$101.78M10.48-C$57.37M-C$0.21-13.29AimiaC$396.20M0.63-C$117M-C$1.33-1.92 Does the media favor CRON or AIM? In the previous week, Cronos Group had 2 more articles in the media than Aimia. MarketBeat recorded 3 mentions for Cronos Group and 1 mentions for Aimia. Aimia's average media sentiment score of 0.49 beat Cronos Group's score of 0.44 indicating that Aimia is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aimia 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, CRON or AIM? Cronos Group has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Aimia has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Do insiders & institutionals have more ownership in CRON or AIM? 16.0% of Cronos Group shares are owned by institutional investors. Comparatively, 31.6% of Aimia shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 3.3% of Aimia shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryAimia beats Cronos Group on 10 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. Get Aimia News Delivered to You Automatically Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIM vs. The Competition Export to ExcelMetricAimiaAsset Management IndustryFinancial SectorTSE ExchangeMarket CapC$250.87MC$981.54MC$3.58BC$6.05BDividend Yield33.90%12.88%4.47%5.43%P/E Ratio-1.92778.32423.7126.16Price / Sales0.632,001.792,182.131,327.99Price / Cash0.5192.8150.8882.04Price / Book0.451.711.503.07Net Income-C$117MC$63.49MC$350.59MC$294.08M7 Day Performance-5.90%-1.91%-1.57%-2.47%1 Month Performance0.79%0.08%0.72%-0.78%1 Year Performance-16.39%7.12%9.93%34.57% Aimia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMAimia2.0706 of 5 starsC$2.55-1.5%C$4.00+56.9%-18.0%C$250.87MC$396.20M-1.9220News CoverageHigh Trading VolumeCRONCronos Group1.0954 of 5 starsC$2.75+0.7%C$3.18+15.6%+12.5%C$1.05BC$101.78M-13.19450News CoverageSLSSolaris Resources1.5537 of 5 starsC$4.42-0.2%C$13.50+205.4%+10.5%C$717.10MN/A-9.8410News CoverageTEVTervitaN/AC$5.81-2.2%N/AN/AC$672.00MC$1.36B-645.5636,800Gap UpABTAbsolute Software Co. (ABT.TO)N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading VolumeNOTNoront ResourcesN/AC$1.10-0.5%N/A+0.0%C$612.18MN/A-7.20101,700PYRPyroGenesis Canada Inc. (PYR.V)N/AC$3.85+11.0%N/A+0.0%C$606.96MC$6.01M-154.0090News CoverageGap UpNVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400DNADalradian ResourcesN/AC$1.46-0.7%N/AN/AC$519.02MN/A-56.15640VBVVBI VaccinesN/AC$4.82-5.1%N/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AC$1.64-0.6%N/AN/AC$306.50MN/A0.0060 Related Companies and Tools Related Companies CRON Competitors SLS Competitors TEV Competitors ABT Competitors NOT Competitors PYR Competitors NVO Competitors DNA Competitors VBV Competitors CUS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:AIM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aimia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aimia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AIM Stock Alerts